Clinical Trials Browser

Phase 1/2 × INDUSTRY × dacetuzumab × Clear all

Hematologic Diseases, Leukemia, Lymphatic Diseases, Lymphoproliferative Disorders, Leukemia, Lymphocytic, Chronic, B-Cell